Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin-Reference-Cited by-同舟云学术

Peptide-modified vemurafenib-loaded liposomes for targeted inhibition of melanoma via the skin

Published:2018-11 Issue: Volume:182 Page:1-12
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Zou Lili,Ding Weiping,Zhang Yuanyuan,Cheng Shaohui,Li Fenfen,Ruan Renquan,Wei Pengfei,Qiu Bensheng

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference59 articles.

1. Recent advances in targeted nanoparticles drug delivery to melanoma;Li;Nanomed-Nanotechnol,2015

2. Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition;Dietrich;Oncogene,2018

3. Vemurafenib for the treatment of BRAF mutant metastatic melanoma;Martin-Liberal;Future Oncol.,2015

4. Nanographene oxide-hyaluronic acid conjugate for photothermal ablation therapy of skin cancer;Jung;ACS Nano,2014

5. Imiquimod enhances the effect of cryotherapy in the management of cutaneous melanoma metastases: a retrospective study of 20 patients;Tolosa;J. Am. Acad. Dermatol.,2015

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved efficacy of linear glutathione-peptide chaperon complexes on melanogenesis inhibition and transdermal delivery;Bioorganic Chemistry;2024-11

2. Exploring the multifaceted effects of silymarin on melanoma: Focusing on the role of lipid-based nanocarriers;Journal of Drug Delivery Science and Technology;2024-09

3. Exploring the therapeutic modalities of targeted treatment approach for skin carcinoma: cutting-edge strategies and key insights;Expert Opinion on Drug Delivery;2024-08-19

4. Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape;European Journal of Pharmaceutics and Biopharmaceutics;2024-07

5. Recent advancements in nanomaterial-mediated ferroptosis-induced cancer therapy: Importance of molecular dynamics and novel strategies;Life Sciences;2024-06